Leonardo DRS returns to the earnings stage August 7 with the mood measurably cooler than it was ahead of the July 30 print — options positioning has flipped from unusually bullish to the most defensively skewed it has been in weeks.
The shift in options is the clearest change from the previous preview. The put/call ratio climbed to 0.31 on August 4, now running more than two standard deviations above its 20-day average of 0.28 — a z-score of 2.4. That is a notable reversal from the sub-0.27 call-skewed reading that preceded the last report. The context matters: DRS fell 8% over the past week, giving back ground after the July print delivered only a modest one-day decline of roughly 1%. That week's pullback appears to have prompted a fresh demand for downside protection. The stock closed at $45.27, still up about 3.5% over the past month but no longer carrying the 16% monthly gain that characterized the earlier setup.
Short interest offers little drama on its own. At 1.1% of the free float — essentially unchanged from the prior preview — there is no meaningful short-seller conviction on either side. Borrow availability remains effectively unlimited, and cost to borrow has edged up about 12% on the week to just 0.50%, a level that signals nothing. The ORTEX short score is steady at 35.7. What that means is that the defensive pivot visible in options has no reinforcement from short sellers building positions; the caution is coming from options hedgers, not from bears adding conviction.
The fundamental debate heading into the print has not changed materially. Bulls point to the $8.9 billion backlog — a record, up 8% year-on-year — and to the Advanced Sensing and Computing segment's 24% growth in new funded bookings. JP Morgan raised its price target to $53 on July 31, keeping a Neutral rating, which captures the Street's mood well: acknowledging momentum while declining to chase it. The mean analyst target of $54.10 implies roughly 19% upside from the current price, with EPS momentum factor scores in the 74th percentile suggesting estimates have been drifting higher. Bears focus on the margin story — EBITDA margins at 12.2% reflect elevated R&D spend and execution friction, and the bear case flags Germanium supply-chain pressure as a lingering headwind into 2026.
Peer context sharpens the picture. Close correlates LHX and RTX each fell less than 1% on the week. DRS's 8% weekly drop is notably steeper, suggesting some stock-specific repositioning rather than pure sector rotation. The August 7 print is therefore less a test of the defense spending narrative — which remains broadly intact across the peer group — and more a test of whether DRS can demonstrate margin recovery and sustain its backlog conversion at a pace that justifies a 32x trailing P/E after a sharp near-term de-rating.
See the live data behind this article on ORTEX.
Open DRS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
